In melanoma, elevated levels of INHBA mRNA (the mRNA that encodes activin) correlate with resistance to anti-PD-1 therapy23 suggesting activin plays a critical role in mediating the PD-1/PD-L1 axis. Here, INHBA is linked to melanoma.